LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China · Delayed Price · Currency is CNY 8.58
-0.24 (-2.72%)
Sep 10, 2026, 3:04 PM CST
SHE:002644 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 926.49 | 915.53 | 980.23 | 1,163 | 1,042 | 817.64 |
Revenue Growth | 1.73% | -6.60% | -15.73% | 11.58% | 27.49% | 22.39% |
Gross Profit Gross Profit Growth | 309.38 | 308.81 | 298.76 | 358.96 | 304.16 | 221.07 |
Operating Income Operating Income Growth | 54.88 | 69.47 | 43.55 | 62.9 | 66.1 | 45.65 |
Net Income Net Income Growth | 58.84 | 49.21 | 60.07 | 67.19 | 108.65 | 93.26 |
Earnings Per Share EPS Growth | 0.12 | 0.10 | 0.12 | 0.13 | 0.21 | 0.18 |
EPS Growth | 8.79% | -18.03% | -10.64% | -38.16% | 16.54% | -13.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 920.05 | 912.36 | 978.12 | 1,161 | 1,009 | 798.52 |
Food Industry Food Industry Growth | 6.44 | 3.17 | 2.11 | 1.8 | 1.66 | 11.94 |
Total Total Growth | 926.49 | 915.53 | 980.23 | 1,163 | 1,042 | 817.64 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 634.61 | 524.49 | 397.89 | 406.04 | 399.85 | 374.94 |
Total Debt Total Debt Growth | 31.8 | 45.49 | 40.79 | 52.63 | 55.6 | 68.65 |
Net Cash (Debt) Net Cash Growth | 602.82 | 479 | 357.1 | 353.41 | 344.26 | 306.29 |
Net Cash Growth | 69.72% | 34.13% | 1.04% | 2.66% | 12.39% | -12.86% |
Net Cash Per Share Net Cash Per Share Growth | 1.18 | 0.94 | 0.70 | 0.69 | 0.67 | 0.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 326.43 | 183.95 | 38.98 | 65.71 | 86.61 | 11.85 |
Capital Expenditures CapEx Growth | -33.81 | -18.55 | -13.29 | -22.47 | -41.53 | -32.81 |
Free Cash Flow Free Cash Flow Growth | 292.62 | 165.4 | 25.7 | 43.24 | 45.08 | -20.95 |
Free Cash Flow Growth | 516.29% | 543.70% | -40.58% | -4.08% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 33.39% | 33.73% | 30.48% | 30.86% | 29.18% | 27.04% |
Operating Margin | 5.92% | 7.59% | 4.44% | 5.41% | 6.34% | 5.58% |
Pretax Margin | 8.07% | 7.10% | 7.05% | 7.02% | 12.54% | 13.55% |
Profit Margin | 6.35% | 5.38% | 6.13% | 5.78% | 10.42% | 11.41% |
FCF Margin | 31.58% | 18.07% | 2.62% | 3.72% | 4.32% | -2.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.120 | 0.020 | 0.012 | 0.030 | 0.050 | 0.010 |
Dividend Per Share Growth | 66.67% | 66.67% | -60.00% | -40.00% | 400.00% | -91.67% |
Dividend Yield | 1.41% | 0.23% | 0.16% | 0.31% | 0.54% | 0.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 74.47 | 89.66 | 65.63 | 74.10 | 43.85 | 54.98 |
Forward PE | - | 53.88 | 53.88 | 53.88 | 53.88 | 53.88 |
P/FCF Ratio | 14.97 | 26.68 | 153.42 | 115.14 | 105.68 | - |
PS Ratio | 4.73 | 4.82 | 4.02 | 4.28 | 4.57 | 6.27 |